SCHEMBL25429424

SCHEMBL25429424

CCC(CC)(C(=O)O)C1CCCCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
HSD11B1 P28845 1/20 0.35
ALDH1A1 P00352 1/20 0.34
NAAA Q02083 1/20 0.34
RECQL P46063 2/20 0.34
EPHX1 P07099 3/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
POLB P06746 1/20 0.33
MEN1 O00255 1/20 0.33
PMP22 Q01453 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12393616 0.98 KEAP1 (0.37) KEAP1NFE2L2HSD11B1ALDH1A1NAAA
SCHEMBL5686257 0.90 KEAP1 (0.33) KEAP1NFE2L2ALDH1A1RECQLEPHX1
SCHEMBL11522217 0.89 MEN1 (0.35) HSD11B1ALDH1A1MEN1KMT2A
SCHEMBL11453750 0.88 CYP2D6 (0.34) KEAP1NFE2L2ALDH1A1NAAARECQL
SCHEMBL29169850 0.88 CHRM2 (0.35) KEAP1NFE2L2ALDH1A1NAAARECQL
SCHEMBL8784444 0.85 KEAP1 (0.31) KEAP1NFE2L2ALDH1A1SMN1; SMN2MEN1
SCHEMBL4870836 0.85 CYP1A2 (0.38) NAAAEPHX1
SCHEMBL27494291 0.85 MEN1 (0.33) KEAP1NFE2L2ALDH1A1SMN1; SMN2MEN1
SCHEMBL17747242 0.81 SHBG (0.34) ALDH1A1MEN1KMT2A
SCHEMBL5197125 0.81 EPHX1 (0.38) HSD11B1ALDH1A1RECQLEPHX1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023148277-A1 AGENTS AND METHODS FOR TARGETED DELIVERY OF NUCLEIC ACIDS TO CELLS BioNTech SE (DE) 2023-08-10 WO disclosed